On September 25, 2025, RIANA Therapeutics took part in the Prague.bio Conference 2025, one of Central and Eastern Europe’s leading events for the biotechnology and life sciences community.
The conference brought together founders, investors, scientists, and innovation leaders from across the region — all sharing a common goal: to strengthen and connect the CEE biotech ecosystem.
We are proud to announce that RIANA Therapeutics was awarded the 1st Prize in the Prague.bio Pitch Competition 🥇, recognizing our innovative work on developing novel STAT5 inhibitors for the treatment of acute myeloid leukemia (AML).
The event featured outstanding talks from keynote speakers Hannah Nelson, Philipp Kukura, and Wojciech Nowak, and was perfectly moderated by Michala Hergetová, whose enthusiasm and professionalism set a great tone for the day.
We extend our warm congratulations to the other winners, HeartBeat.bio AG and Nanoflexion, and our sincere thanks to the entire Prague.bio team for organizing such a well-curated and inspiring event.
We left Prague energized and deeply motivated by the spirit of collaboration and innovation driving biotech in Central Europe.
We’re already looking forward to BioEquity Europe 2026, which will take place in Prague next May – another great opportunity to strengthen international ties and showcase the potential of our region’s biotech startups.
RIANA Therapeutics 